Interleukin-1 muteins useful as vaccine adjuvants

The present invention concerns compositions comprising an IL-1 mutein that is useful as an adjuvant for stimulating a controlled immune response when administered to a human or animal. For example, muteins of IL-1beta can be used according to the invention. The mutein composition can include a vacci...

Full description

Saved in:
Bibliographic Details
Main Authors DONDERO RICHARD S, STAATS HERMAN F
Format Patent
LanguageEnglish
Published 16.12.2004
Edition7
Subjects
Online AccessGet full text

Cover

Loading…